Free Trial
CVE:COV

Covalon Technologies (COV) Stock Price, News & Analysis

Covalon Technologies logo
C$3.44
0.00 (0.00%)
(As of 11/4/2024 05:19 PM ET)

About Covalon Technologies Stock (CVE:COV)

Key Stats

Today's Range
C$3.40
C$3.44
50-Day Range
C$2.95
C$3.44
52-Week Range
C$0.96
C$3.46
Volume
18,565 shs
Average Volume
19,455 shs
Market Capitalization
C$94.26 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity. It also offers medical coating platform, a process that utilizes photo-polymerization to create active grafting sites where new polymer chains are initiated and propagated from the surface of an existing medical device. In addition, the company provides wound care dressings; surgical and peri-operative; and infection management products. It offers its products under the Covalon brand name through third-party distribution networks and company's direct sales force. The company serves hospitals, wound care centers, burn centers, extended/alternate care and acute care facilities, home health care agencies, and physicians' offices. Covalon Technologies Ltd. is headquartered in Mississauga, Canada.

Receive COV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Covalon Technologies and its competitors with MarketBeat's FREE daily newsletter.

COV Stock News Headlines

COV:CA Covalon Technologies Ltd.
2 sentences that change everything you THOUGHT you knew about trading
If you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfast... go to work... But if you say these two sentences to your broker... you could collect as much as $1,250 on Friday... no matter where you live, whether you're working or already retired. It all has to do with a unique stock market secret that's worked 97% of the time for the past 8 years running.
CVALF Covalon Technologies Ltd.
See More Headlines

COV Stock Analysis - Frequently Asked Questions

Covalon Technologies' stock was trading at C$1.06 at the beginning of the year. Since then, COV shares have increased by 224.5% and is now trading at C$3.44.
View the best growth stocks for 2024 here
.

Covalon Technologies Ltd. (CVE:COV) announced its earnings results on Wednesday, August, 21st. The company reported $0.06 earnings per share for the quarter. The firm earned $9.22 million during the quarter. Covalon Technologies had a negative trailing twelve-month return on equity of 3.85% and a negative net margin of 2.82%.

Shares of COV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Covalon Technologies investors own include NIO (NIO), Reliq Health Technologies (RHT), Facedrive (FDVRF), Meta Platforms (META), NVIDIA (NVDA), Ackroo (AKR) and BeWhere (BEW).

Company Calendar

Last Earnings
8/21/2024
Today
11/05/2024
Next Earnings (Estimated)
1/24/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
C$-2,770,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$29.20 million
Cash Flow
C$0.80 per share
Book Value
C$0.88 per share

Miscellaneous

Free Float
N/A
Market Cap
C$94.26 million
Optionable
Not Optionable
Beta
0.64
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (CVE:COV) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners